Search Results - "Wens, C."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Quantification of Diaphragm Mechanics in Pompe Disease Using Dynamic 3D MRI by Mogalle, Katja, Perez-Rovira, Adria, Ciet, Pierluigi, Wens, Stephan C A, van Doorn, Pieter A, Tiddens, Harm A W M, van der Ploeg, Ans T, de Bruijne, Marleen

    Published in PloS one (08-07-2016)
    “…Diaphragm weakness is the main reason for respiratory dysfunction in patients with Pompe disease, a progressive metabolic myopathy affecting respiratory and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Perioperative outcomes of revisional laparoscopic gastric bypass after failed adjustable gastric banding and after vertical banded gastroplasty: experience with 107 cases and subgroup analysis by Apers, J. A., Wens, C., van Vlodrop, V., Michiels, M., Ceulemans, R., van Daele, G., Jacobs, I.

    Published in Surgical endoscopy (01-02-2013)
    “…Background A growing number of revision procedures are to be expected in bariatric surgery after failed restrictive procedures such as failed adjustable…”
    Get full text
    Journal Article
  4. 4

    Lung MRI and impairment of diaphragmatic function in Pompe disease by Wens, Stephan C A, Ciet, Pierluigi, Perez-Rovira, Adria, Logie, Karla, Salamon, Elizabeth, Wielopolski, Piotr, de Bruijne, Marleen, Kruijshaar, Michelle E, Tiddens, Harm A W M, van Doorn, Pieter A, van der Ploeg, Ans T

    Published in BMC pulmonary medicine (06-05-2015)
    “…Pompe disease is a progressive metabolic myopathy. Involvement of respiratory muscles leads to progressive pulmonary dysfunction, particularly in supine…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Phenotypical variation within 22 families with Pompe disease by Wens, Stephan C A, van Gelder, Carin M, Kruijshaar, Michelle E, de Vries, Juna M, van der Beek, Nadine A M E, Reuser, Arnold J J, van Doorn, Pieter A, van der Ploeg, Ans T, Brusse, Esther

    Published in Orphanet journal of rare diseases (19-11-2013)
    “…Pompe disease has a broad clinical spectrum, in which the phenotype is partially explained by the genotype. The aim of this study was to describe phenotypical…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Long-term benefit of enzyme replacement therapy in Pompe disease: A 5-year prospective study by Kuperus, Esther, Kruijshaar, Michelle E, Wens, Stephan C.A, de Vries, Juna M, Favejee, Marein M, van der Meijden, Jan C, Rizopoulos, Dimitris, Brusse, Esther, van Doorn, Pieter A, van der Ploeg, Ans T, van der Beek, Nadine A.M.E

    Published in Neurology (05-12-2017)
    “…OBJECTIVE:To determine the effect of enzyme replacement therapy (ERT) after 5 years and to identify predictors for a favorable response because few data are…”
    Get full text
    Journal Article
  9. 9

    Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease by Wens, Stephan C.A., Kroos, Marian A., de Vries, Juna M., Hoogeveen-Westerveld, Marianne, Wijgerde, Mark G.J.M., van Doorn, Pieter A., van der Ploeg, Ans T., Reuser, Arnold J.J.

    Published in Molecular genetics and metabolism (01-11-2012)
    “…Most adults with Pompe disease are compound heterozygotes in which one acid α-glucosidase (GAA) allele harbors the c.-32-13T>G mutation, causing partial loss…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13